26 January 2020

Oncode researchers gain access to Organoid technology thanks to collaboration with KNAW

Thanks to an agreement between the Royal Netherlands Academy of Arts and Sciences (KNAW) and Oncode Institute, the organoid technology will become available to all 800+ cancer researchers that are part of Oncode. The KNAW collaborates with its institutional partner UMC Utrecht on organoid technology. Thanks to this agreement with Oncode, researchers receive a license to conduct research on organoids for the first time in the Netherlands.

Elize Brolsma

Growing and researching organoids is a technology developed by Oncode researcher Hans Clevers. Clevers works - among others - at the Hubrecht Institute (KNAW) and the UMC Utrecht and is a professor at Utrecht University. The KNAW manages the licenses for the use of this technology together with UMC Utrecht. For the quality of cancer research, it is a unique step that unlimited research for academic purposes is now possible. The use of organoids allows researchers to analyze tumor growth with limited amounts of tissue from patients, to investigate genetic instability and to test new drug combinations.

Angus Livingstone, Valorization Director at Oncode Institute, says: “We are particularly proud that all researchers that are part of Oncode Institute now have unlimited access to this promising technology. An important goal of Oncode is to bring research results from the lab to patients faster. This agreement with KNAW is a good example of how we make this possible."

Mieke Zaanen, Managing Director of the KNAW, adds: “Fantastic research is being done within the national research institutes of the KNAW, which often leads to results that have a great impact. Thanks to Oncode Institute, this technology is now becoming more widely available which can make a difference for large and small groups of patients."

Arno Hoes, vice-chair of the executive board of UMC Utrecht and dean of the medicine faculty: "We think it is very important that this technology developed in Utrecht is widely used and we are pleased with this agreement.”

Cancer researchers who are not affiliated with Oncode that are interested to use this technology can contact KNAW.

Intestinal organoid, credit: Joep Beumer, copyright Hubrecht Institute

Other News

Kops website
New biosensor measures activity of control enzyme MPS1
Researchers from the group of Oncode Investigator Geert Kops (Hubrecht Institute) have developed a biosensor that can precisely depict the activity of the MPS1 enzyme in living cells. MPS1 is responsible for accurate distribution of DNA during cell division; errors in this process can lead to cancer. Using the new biosensor, the researchers discovered that the MPS1 enzyme is significantly less active in colorectal cancer cells. The results were published in the scientific journal Current Biology on the 3rd of September.
Pre-existing immune-resistant cancer cells identified in melanoma
Researchers at the Netherlands Cancer Institute, led by Oncode Investigator Daniel Peeper with Julia Boshuizen as first author, have discovered a cluster of tumor cells that are refractory to immunotherapy and that exists even prior to treatment. This finding, which was published in the scientific journal Nature Communications, may lead to new therapies that eliminate cancer more effectively.


Elize is part of Oncode’s communication team. She has over 10 years of experience in the com-munication industry, both for commercial and non-profit organisations. After obtaining her bache-lor and master degree in communication at Utrecht University, Elize worked as a communication professional at a research institute, PR agency, law firm and internet company. She has a strong focus on external communications and Public Relations. At Oncode - together with her colleagues - Elize produces the monthly newsletters for Oncode Investigators & Researchers and the Oncode digital magazine. She publishes content for the Oncode website and is responsible for all social media channels. She enjoys discussing science with researchers and support them in their outreach.
11 impact value 1
Convey impact, get funding
In order to give our community hands-on advice on how to improve their grant writing, we hosted a 90- minute interactive webinar: Get Funding: Convey the impact of your science.